The role of RIPK1 in chronic obstructive pulmonary disease

Drug Discov Today. 2024 May 11;29(7):104020. doi: 10.1016/j.drudis.2024.104020. Online ahead of print.

Abstract

Necroptosis has emerged as one of the crucial pathological processes involved in the regulation of cell death and inflammation in chronic obstructive pulmonary disease (COPD). Airway epithelial necroptosis is closely linked to COPD pathogenesis. Necroptotic lung cells can release damage-associated molecular patterns (DAMPs) that can initiate a robust inflammatory response. However, the underlying mechanism of necroptosis in COPD is still not clearly understood. Therefore, we aimed to explore the roles and mechanisms of receptor-interacting serine/threonine-protein kinase 1 (RIPK1)-mediated necroptosis in the regulation of inflammatory responses in COPD to provide insights into RIPK1-inhibitor drug discovery efforts and their therapeutic benefits in COPD.

Keywords: RIPK1; chronic obstructive pulmonary disease; lung inflammation; lung remodelling; necroptosis.

Publication types

  • Review